Berberine is a potential alternative for metformin with good regulatory effect on lipids in treating metabolic diseases - Guo, Hui-Hui; Shen, Hao-Ran; Wang, Lu-Lu; Luo, Zhi-Gang; Zhang, Jin-Lan; Zhang, Hong-Juan; Gao, Tian-Le; Han, Yan-Xing; Jiang, Jian-Dong (Biomedicine & pharmacotherapy, 2023)
Keywords: Animals; Bacteria-derived metabolites; Berberine; Berberine - pharmacology; Berberine - therapeutic use; Cricetinae; Gut barrier; Gut microbiota; Hyperlipidemias - drug therapy; Lipids - therapeutic use; Metabolic-related disorders; Metformin; Metformin - pharmacology; Metformin - therapeutic use; Mice; Obesity - drug therapy; TMAO; Gut microbiota; Bacteria-derived metabolites; T2DM; NAFLD; HFD; ALT; PCSK9; CHO; LPS; CEs; BBR; BAs; LDLR; Berberine; LDL-c; InsR; TMA; SREBP-1c; PPARγ; Metabolic-related disorders; TG; AB-PAS; Gut barrier; AMPK; SCFAs; Metformin; MTF